A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3. (Q42068164)

16 October 2017

A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3. (English)

1 reference

16 October 2017

Du RP

1

1 reference

16 October 2017

Jackson GE

2

1 reference

16 October 2017

Wyde PR

3

1 reference

16 October 2017

Yan WY

4

1 reference

16 October 2017

Wang Q

5

1 reference

16 October 2017

Gisonni L

6

1 reference

16 October 2017

Sanhueza SE

7

1 reference

16 October 2017

Klein MH

8

1 reference

16 October 2017

Ewasyshyn ME

9

1 reference

16 October 2017

1 August 1994

1 reference

16 October 2017

1 reference

16 October 2017

12

1 reference

16 October 2017

813-818

1 reference

16 October 2017

8

1 reference

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

16 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Antibody response in children to antigen sites on human PIV-3 HN: correlation with known epitopes mapped by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Molecular cloning and sequence analysis of the human parainfluenza 3 virus genes encoding the surface glycoproteins, F and HN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Dideoxy sequencing method using denatured plasmid templates

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FNBT0894-813

7 January 2021

Identifiers

DOI

10.1038/NBT0894-813

1 reference

16 October 2017

1 reference